174 related articles for article (PubMed ID: 24486368)
1. Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells.
Santos-Gomes GM; Rodrigues A; Teixeira F; Carreira J; Alexandre-Pires G; Carvalho S; Santos-Mateus D; Martins C; Vale-Gato I; Marques C; Tomás AM
Vaccine; 2014 Mar; 32(11):1247-53. PubMed ID: 24486368
[TBL] [Abstract][Full Text] [Related]
2. Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte.
Rodrigues A; Claro M; Alexandre-Pires G; Santos-Mateus D; Martins C; Valério-Bolas A; Rafael-Fernandes M; Pereira MA; Pereira da Fonseca I; Tomás AM; Santos-Gomes G
Immunobiology; 2017 Feb; 222(2):409-422. PubMed ID: 27615509
[TBL] [Abstract][Full Text] [Related]
3. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection.
Silva AM; Tavares J; Silvestre R; Ouaissi A; Coombs GH; Cordeiro-da-Silva A
Parasite Immunol; 2012 Jun; 34(6):345-50. PubMed ID: 22416787
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response.
Rosa R; Marques C; Rodrigues OR; Santos-Gomes GM
Vaccine; 2007 Jun; 25(23):4525-32. PubMed ID: 17478016
[TBL] [Abstract][Full Text] [Related]
6. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
Carrión J; Folgueira C; Alonso C
Vaccine; 2008 May; 26(20):2537-44. PubMed ID: 18400342
[TBL] [Abstract][Full Text] [Related]
7. Canine Leishmania vaccines: still a long way to go.
Gradoni L
Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
[TBL] [Abstract][Full Text] [Related]
8. A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.
Martins VT; Lage DP; Duarte MC; Costa LE; Garde E; Rodrigues MR; Chávez-Fumagalli MA; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
Acta Trop; 2016 Feb; 154():73-81. PubMed ID: 26593442
[TBL] [Abstract][Full Text] [Related]
9. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.
Leal JM; Mosquini M; Covre LP; Stagmiller NP; Rodrigues RR; Christensen D; de Matos Guedes HL; Rossi-Bergmann B; Gomes DC
Parasitology; 2015 Nov; 142(13):1640-6. PubMed ID: 26394776
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis.
Martins VT; Chávez-Fumagalli MA; Lage DP; Duarte MC; Garde E; Costa LE; da Silva VG; Oliveira JS; Magalhães-Soares DF; Teixeira SM; Fernandes AP; Soto M; Tavares CA; Coelho EA
PLoS One; 2015; 10(9):e0137683. PubMed ID: 26367128
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
12. Identification of regulatory T cells during experimental Leishmania infantum infection.
Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM
Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.
Daifalla NS; Bayih AG; Gedamu L
Exp Parasitol; 2012 Jul; 131(3):317-24. PubMed ID: 22580023
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
Pereira L; Abbehusen M; Teixeira C; Cunha J; Nascimento IP; Fukutani K; dos-Santos W; Barral A; de Oliveira CI; Barral-Netto M; Soto M; Brodskyn CI
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003490. PubMed ID: 25642946
[TBL] [Abstract][Full Text] [Related]
16. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
18. Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge.
Ferrua B; Luci C; Le Fichoux Y; Paul A; Marty P
Vaccine; 2006 Jan; 24(5):589-96. PubMed ID: 16157427
[TBL] [Abstract][Full Text] [Related]
19. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
20. A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection.
Duarte MC; Lage DP; Martins VT; Costa LE; Lage LM; Carvalho AM; Ludolf F; Santos TT; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CA; Coelho EA
Mol Immunol; 2016 Aug; 76():70-9. PubMed ID: 27387277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
